A Cross-Study Analysis Evaluating the Effects of Food on the Pharmacokinetics of Rivaroxaban in Clinical Studies-Reference-Cited by-同舟云学术

A Cross-Study Analysis Evaluating the Effects of Food on the Pharmacokinetics of Rivaroxaban in Clinical Studies

Published:2017-07-05 Issue:12 Volume:57 Page:1607-1615
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Zhang Liping¹,Peters Gary¹,Haskell Lloyd¹,Patel Purve¹,Nandy Partha¹,Moore Kenneth Todd²

Affiliation:

1. Janssen Research & Development; LLC; Raritan NJ USA

2. Janssen Scientific Affairs; LLC; Titusville NJ USA

Funder

Janssen Research and Development

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcph.958/fullpdf

Reference18 articles.

1. XARELTO® XARELTO® (rivaroxaban) tablets, for oral use Titusville, NJ Janssen Pharmaceuticals, Inc. 2015

2. Bayer Pharma AG. ® 2015

3. The effect of food on the absorption and pharmacokinetics of rivaroxaban;Stampfuss;Int J Clin Pharmacol Ther,2013

4. Guidance for Industry: Food-effect bioavailability and fed bioequivalence studies;US Department of Health and Human Services;Food and Drug Administration Center for Drug Evaluation and Research

5. Rivaroxaban crushed tablet suspension characteristics and relative bioavailability in healthy adults when administered orally or via nasogastric tube;Moore;Clin Pharmacol Drug Develop,2014

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticoagulation strategy for patients presenting with ischemic strokes while using a direct oral anticoagulant: A systematic review and meta-analysis;International Journal of Stroke;2024-08-09

2. Bioequivalence Study of Capsules versus Film Tablets Containing Rivaroxaban in Healthy Caucasian Subjects under Fasting and Fed Conditions;Clinical Pharmacology in Drug Development;2023-11-23

3. Pharmacokinetics, Bioequivalence, and Safety Evaluation of 2 Formulations of 10‐mg Rivaroxaban Tablets: A 4‐Period Crossover Trial;Clinical Pharmacology in Drug Development;2023-05-21

4. Transferability of Published Population Pharmacokinetic Models for Apixaban and Rivaroxaban to Subjects with Obesity Treated for Venous Thromboembolism: A Systematic Review and External Evaluations;Pharmaceutics;2023-02-16

5. Is a Lower Dose of Rivaroxaban Required for Asians? A Systematic Review of a Population Pharmacokinetics and Pharmacodynamics Analysis of Rivaroxaban;Pharmaceutics;2023-02-09